Cholangitis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:


==Natural History==
==Natural History==
Acute cholangitis is the result of a bacterial infection that causes partial or complete obstruction of the [[biliary system]]. Patients with the disease present with a wide range of severity, from low-grade [[fever]] to severe [[sepsis]]. Patients usually present with Charcot's triad which is fever, abdominal pain and jaundice. Shock with [[pus]] within the biliary tree is indicative of acute suppurative cholangitis. Patients present with Reynold's pentad that comprises sepsis and mental confusion in addition.<ref name="book123">{{Citation
Acute cholangitis is the result of a bacterial infection that causes partial or complete obstruction of the [[biliary system]]. Patients with the disease present with a wide range of severity, from low-grade [[fever]] to severe [[sepsis]]. Patients usually present with Charcot's triad which is [[fever]], [[abdominal pain and jaundice]]. Shock with [[pus]] within the biliary tree is indicative of acute suppurative cholangitis. Patients present with Reynold's pentad that comprises [[sepsis]] and [[mental confusion]] in addition.<ref name="book123">{{Citation
| last1  = Liu
| last1  = Liu
| first1 = CL
| first1 = CL
Line 34: Line 34:
*[[Pancreatitis]]  
*[[Pancreatitis]]  


The risk of complications increased in subsequent years after gallbladder stones were first discovered, but have been decreasing since. Every year, 6-8% of patients whose symptoms progress from minor to serious undergo [[cholecystectomy]]. Fortunately, this percentage has been decreasing yearly.<ref name="pmid17252293">{{cite journal |vauthors=Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR |title=Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines |journal=J Hepatobiliary Pancreat Surg |volume=14 |issue=1 |pages=15–26 |year=2007 |pmid=17252293 |pmc=2784509 |doi=10.1007/s00534-006-1152-y |url=}}</ref>
The risk of complications increased in subsequent years after [[Gall stones|gallbladder stones]] were first discovered, but have been decreasing since. Every year, 6-8% of patients whose symptoms progress from minor to serious undergo [[cholecystectomy]]. Fortunately, this percentage has been decreasing yearly.<ref name="pmid17252293">{{cite journal |vauthors=Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR |title=Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines |journal=J Hepatobiliary Pancreat Surg |volume=14 |issue=1 |pages=15–26 |year=2007 |pmid=17252293 |pmc=2784509 |doi=10.1007/s00534-006-1152-y |url=}}</ref>


==Prognosis==
==Prognosis==

Revision as of 15:03, 12 December 2017

Cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangitis natural history, complications and prognosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangitis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangitis natural history, complications and prognosis

CDC on Cholangitis natural history, complications and prognosis

Cholangitis natural history, complications and prognosis in the news

Blogs on Cholangitis natural history, complications and prognosis

Directions to Hospitals Treating Cholangitis

Risk calculators and risk factors for Cholangitis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farwa Haideri [2]

Overview

Patients who show early signs of multiple organ failure (renal failure, disseminated intravascular coagulation, alterations in the level of consciousness, and shock) or evidence of acute cholangitis, as well as those who do not respond to conservative treatment, should receive systemic antibiotics and undergo emergent biliary drainage. Unless early and appropriate biliary drainage is performed and systemic antibiotics are administered, death will occur. The prognosis is usually good with treatment but poor without treatment.

Natural History

Acute cholangitis is the result of a bacterial infection that causes partial or complete obstruction of the biliary system. Patients with the disease present with a wide range of severity, from low-grade fever to severe sepsis. Patients usually present with Charcot's triad which is fever, abdominal pain and jaundice. Shock with pus within the biliary tree is indicative of acute suppurative cholangitis. Patients present with Reynold's pentad that comprises sepsis and mental confusion in addition.[1] A history of biliary disease, such as gallstones, previous biliary procedures, or the placement of a biliary stent are factors that are very helpful in understanding the natural history of cholangitis.[2]

Complications

Complications related to cholangitis include:[3][4]

The risk of complications increased in subsequent years after gallbladder stones were first discovered, but have been decreasing since. Every year, 6-8% of patients whose symptoms progress from minor to serious undergo cholecystectomy. Fortunately, this percentage has been decreasing yearly.[4]

Prognosis

Acute cholangitis bears a significant risk of death, with the leading cause being irreversible shock with multiple organ failure (which could have multiple possible complications of severe infections). Modern improvements in diagnosis and treatment have led to a reduction in mortality. Before 1980, the mortality rate was greater than 50%; in the past thirty years, it has decreased to 10-30%. These differences in mortality can likely be attributed to improvements in early diagnosis and supportive treatment. Patients with signs of multiple organ failure are likely to die unless they undergo early biliary drainage and treatment with systemic antibiotics. Other causes of death following severe cholangitis include heart failure and pneumonia.[3][4]

References

  1. Liu, CL & Fan, ST (2001), Surgical Treatment: Evidence-Based and Problem-Oriented (24 ed.), Munich, Germany: Zuckschwerdt
  2. Miura F, Takada T, Kawarada Y, Nimura Y, Wada K, Hirota M, Nagino M, Tsuyuguchi T, Mayumi T, Yoshida M, Strasberg SM, Pitt HA, Belghiti J, de Santibanes E, Gadacz TR, Gouma DJ, Fan ST, Chen MF, Padbury RT, Bornman PC, Kim SW, Liau KH, Belli G, Dervenis C (2007). "Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 27–34. doi:10.1007/s00534-006-1153-x. PMC 2784508. PMID 17252294.
  3. 3.0 3.1 Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK, Wong J (1990). "Emergency surgery for severe acute cholangitis. The high-risk patients". Ann. Surg. 211 (1): 55–9. PMC 1357893. PMID 2294844.
  4. 4.0 4.1 4.2 Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR (2007). "Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 15–26. doi:10.1007/s00534-006-1152-y. PMC 2784509. PMID 17252293.


Template:WikiDoc Sources